RT Journal Article
SR Electronic
T1 Prevalence and risk factors of chronic kidney disease in a populated area with highly moving populations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.10.19.20215004
DO 10.1101/2020.10.19.20215004
A1 Khajedaluee, Mohammad
A1 Ghezeldasht, Sanaz Ahmadi
A1 Mosavat, Arman
A1 Hekmat, Reza
A1 Rezaee, Seyed Abdolrahim
A1 Hassannia, Tahereh
YR 2020
UL http://medrxiv.org/content/early/2020/10/21/2020.10.19.20215004.abstract
AB Background Chronic kidney disease (CKD) is a major public health problem worldwide. Prevalence and associated risk factors of CKD was evaluated in the greater Mashhad, a highly populated pilgrimage city, in 2018 on 2,976 subjects.Methods This study was carried out in the greater Mashhad, a highly populated pilgrimage city, in 2018 on 2,976 subjects. For each participant a standard questionnaire, a physical examination and clinical history were completed. Then biochemical and hematologic tests for kidney function were performed.Results Obesity was observed more frequently in subjects with CKD, thus BMI was positively correlated with the prevalence of CKD (p<0.001). Moderately reduced GFR was found in 17.6% and 7.1%, and severely reduce GFR at 0.7% and 0.5%, of males and females, respectively (p<0.001).Drug abuse also showed a strong association with CKD (p=0.004), but smoking did not. Using univariate and multivariate logistic regression of decreased estimated GFR<60 showed that age (OR=1.06), gender (OR=2.14), diabetes (OR=1.07), hypertension (OR=1.39) and drug usage (OR=3.29) were risk factors for CKD; BMI was not. The same statistics showed that only age (OR=1.02), diabetes (OR=2.61) and hypertension (OR=1.16) were risk factors for albuminuria. The prevalence of hypertension (22.1%) was a risk factor for CKD, and vice versa. BMI and drug abuse were also risk factors for hypertension, but not smoking.Conclusion These findings demonstrated that progression of CKD and hypertension in any population should be considered in the context of changes in human behaviours, etiology, disease severity, co-occurring diseases, addiction and priority of therapy over prevention.Competing Interest StatementThe authors have declared no competing interest.Funding StatementOnly for sampling and parts of laboratory tests the Mashhad university of medical sciences has been granted the study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:[IR.MUMS.REC.87099]All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll of the row data, SPSS file, statistical analysis and the original materials (except the urine samples) are available.Al/Cralbumin-to-creatinine ratioBMIBody mass indexCGCockcroft and GaultCKDChronic kidney diseaseCKD-EPIChronic Kidney Disease Epidemiology CollaborationCVDcardiovascular diseaseESRDend-stage renal diseaseGFRglomerular filtration rateKDOQIKidney Disease Outcome Quality InitiativeMDRDModification of Diet in Renal DiseaseRBCRed blood cellsTCtotal cholesterolTGtriglycerideWBCWhite blood cells